Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S302000, C514S303000, C514S313000, C546S114000, C546S115000, C546S120000, C546S162000
Reexamination Certificate
active
06946473
ABSTRACT:
Compounds of the formulawhich are useful in disease conditions mediated by TNF-α, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
REFERENCES:
patent: 5455258 (1995-10-01), MacPherson et al.
patent: 5506242 (1996-04-01), MacPherson et al.
patent: 5552419 (1996-09-01), MacPherson et al.
patent: 5606063 (1997-02-01), Harrison et al.
patent: 5753653 (1998-05-01), Bender et al.
patent: 5770624 (1998-06-01), Parker
patent: 5804593 (1998-09-01), Warpehoski et al.
patent: 5817822 (1998-10-01), Nantermet et al.
patent: 5929097 (1999-07-01), Levin et al.
patent: 19542189 (1997-05-01), None
patent: 606046 (1993-12-01), None
patent: 757037 (1996-07-01), None
patent: 757984 (1996-08-01), None
patent: 803505 (1997-04-01), None
patent: WO 9535275 (1995-12-01), None
patent: WO 9535276 (1995-12-01), None
patent: WO 9600214 (1996-01-01), None
patent: WO 9627583 (1996-09-01), None
patent: WO 9633172 (1996-10-01), None
patent: WO 9718194 (1997-05-01), None
patent: WO 9719068 (1997-05-01), None
patent: WO 9720824 (1997-06-01), None
patent: WO 9722587 (1997-06-01), None
patent: WO 9727174 (1997-07-01), None
patent: WO 9745402 (1997-12-01), None
patent: WO 9803166 (1998-01-01), None
patent: WO 9807697 (1998-02-01), None
patent: WO 9808815 (1998-03-01), None
patent: WO 9808822 (1998-03-01), None
patent: WO 9808823 (1998-03-01), None
patent: WO 9808825 (1998-03-01), None
patent: WO 9808827 (1998-03-01), None
patent: WO 9808853 (1998-03-01), None
patent: WO 9816503 (1998-04-01), None
patent: WO 9816506 (1998-04-01), None
patent: WO 9816514 (1998-04-01), None
patent: WO 9816520 (1998-04-01), None
patent: WO 9833768 (1998-08-01), None
patent: WO 9834918 (1998-08-01), None
patent: WO 9837877 (1998-09-01), None
patent: WO 9839313 (1998-09-01), None
patent: WO 9839329 (1998-09-01), None
patent: WO 9842659 (1998-10-01), None
patent: WO 9843963 (1998-10-01), None
patent: WO 9925687 (1999-05-01), None
patent: WO 0044709 (2000-08-01), None
Anonymous, “Enbrel® (etanercept)” 2004, [online]. Philadelphia, PA Wyeth Pharmaceuticals Inc., [retrieved on Nov. 26, 2004]. Retrieved from the Internet <http://www.enbrel.com/>.
Anonymous, “REMICADE® (infliximab)” Oct. 8, 2004 , [online]. Centocor, Inc. , [retrieved on Nov. 26, 2004]. Retrieved from the Internet <http://www.remicade.com/>.
Roy A. Black, The International Journal of Biochemistry & Cell Biology vol. 34, Issue 1 , Jan. 2002, pp. 1-5.
Conway, J.G. et al, J Pharmacol Exp Ther. Sep. 2001;298(3):900-8.
Beck, G. et al, J Pharmacol Exp Ther. Jul. 2002;302(1):390-6.
Levin, J.I. et al, Bioorg Med Chem Lett. Aug. 18, 2003;13(16):2799-803.
Shire, M.G., Exp. Opin. Ther. Patents 8(5), 531 (1998).
Grossman, J.M., Women's Health, 6(6), 627 (1997).
Isomaki, P.J., Ann. Med., 29, 499 (1997).
Camussi, G., Drugs, 55(5), 613 (1998).
Mathison et al., J. Clin. Invest., 81, 1925, (1988).
Miethke et al., J. Exp. Med., 175, 91 (1992).
Piquet, P. F., J. Exp. Med. 166, 1280 (1987).
Beuther, B., Ann. Rev., Biochem, 57, 505 (1988).
Ksontini, R., Arch, Surg., 133, 558, (1998).
Packer, M., Circulation, 92(6), 1379 (1995).
Ferrari, R., et al., Circulation 92(6), 1479 (1995).
Hotamisligil, G.S. et al., Science, 259, 87 (1993).
Peterson, P.K. et al., J. Clin. Invest., 89, 574 (1992).
Pallares-Trujillo et al., Med. Res. Reviews, 15(6), 533 (1995).
Old, L., Science, 230, 630 (1985).
Rankin, E.C. et al., Br. J. Rheumatol., 34, 334 (1995).
Pharmaprojects, Therapeutic Updates 17 (Oct.) au 197, M2Z (1996).
Mc Geehan et al., Current Pharmaceutical Design, 2, 662 (1996).
Script 20, 2349 (1998).
Mac Pherson et al., J. Med. Chem., 40, 2525 (1997).
Tamura et al., J. Med. Chem. 41, 640 (1998).
Pikul et al., J. Med. Chem., 41, 3568 (1998).
Albright Jay D.
Chen James M.
Du Xue-Mei
Levin Jeremy I.
Zask Arie
McKenzie Thomas C.
Wyeth Holdings Corporation
LandOfFree
Preparation and use of acetylenic ortho-sulfonamido and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation and use of acetylenic ortho-sulfonamido and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation and use of acetylenic ortho-sulfonamido and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3381453